e-learning
resources
Munich 2014
Sunday, 07.09.2014
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum processing methods in airway disease: Which is best?
M. Rainer, F. Haider, P. Marks, R. McCartney, J. Rezulski, S. Greenaway, G. MacGregor, G. Clarke (London, Glasgow, United Kingdom)
Source:
International Congress 2014 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster Session
Number:
998
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Rainer, F. Haider, P. Marks, R. McCartney, J. Rezulski, S. Greenaway, G. MacGregor, G. Clarke (London, Glasgow, United Kingdom). Sputum processing methods in airway disease: Which is best?. Eur Respir J 2014; 44: Suppl. 58, 998
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Induced sputum and bronchial hyperresponsiveness in COPD patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Assessment of oxidative stress in cystic fibrosis using malondialdehyde
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Mucus production, lung inflammation and functional decay in IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Small airways obstruction and exhaled particles in asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Asthma control is not related to large airways function
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Non-invasive evaluation of airway inflammation in non-CF bronchiectasis
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Change of mucus rheology in patients with Cystic Fibrosis, COPD and Asthma
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Evaluation of three categorical sputum colour charts: is less more?
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Sputum neutrophil differential cell count in health and relationship to disease severity in asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Surfactant protein expression at various COPD Gold stages
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid
Source: International Congress 2014 – ILDs 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept